SEARCH

SEARCH BY CITATION

References

  • 1
    Jarvelainen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology 2001; 33:11481153.MEDLINE
  • 2
    Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD. A Polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999; 20:976983.MEDLINE
  • 3
    Stemerowicz R, Moller B, Martin P, Heesemann J, Wenzel BE, Galanos C, Freudenberg M, et al. Antibody activity against lipopolysaccharides, lipid A and proteins from Enterobacteriaceae in patients with chronic inflammatory liver diseases. Autoimmunity 1990; 7:305315.MEDLINE
  • 4
    Ide T, Sata M, Nakano H, Suzuki H, Tanikawa K. Increased serum IgM class anti-lipid A antibody and therapeutic effect of ursodeoxycholic acid in primary biliary cirrhosis. Hepatogastroenterology 1997; 44:15691573.MEDLINE
  • 5
    Yamamoto Y, Sezai S, Sakurabayashi S, Hirano M, Kamisaka K, Oka H. A study of endotoxaemia in patients with primary biliary cirrhosis. J Int Med Res 1994; 22:9599.MEDLINE
  • 6
    Sakisaka S, Koga H, Sasatomi K, Mimura Y, Kawaguchi T, Tanikawa K. Biliary secretion of endotoxin and pathogenesis of primary biliary cirrhosis. Yale J Biol Med 1997; 70:403408.MEDLINE
  • 7
    Ide T, Sata M, Suzuki H, Uchimura Y, Murashima S, Shirachi M, Tanikawa K. An experimental animal model of primary biliary cirrhosis induced by lipopolysaccharide and pyruvate dehydrogenase. Kurume Med J 1996; 43:185188.MEDLINE
  • 8
    Iwata M, Harada K, Hiramatsu K, Tsuneyama K, Kaneko S, Kobayashi K, Nakanuma Y. Fas ligand expressing mononuclear cells around intrahepatic bile ducts co-express CD68 in primary biliary cirrhosis. Liver 2000; 20:129135.MEDLINE